| Abstract | Tuberculosis remains a major health problem worldwide. Recently developed diagnostic blood tests may supplant or supplement TB skin test in some settings. Emergence of drug-resistant strains remains a global concern. New anti-tuberculous agents are being developed and are greatly needed. There is mounting evidence that BCG has significant effectiveness in prevention, but development of improved vaccines for tuberculosis should remain a priority. |
| Authors | Charles R Woods
(Affiliation: Winston-Salem, North Carolina, USA. cwoods at wfubmc.edu)
|
| Journal | Paediatric respiratory reviews
(Paediatr Respir Rev)
Vol. 7 Suppl 1
Pg. S130-1
( 2006)
ISSN: 1526-0542 England |
| PMID | 16798538
(Publication Type: Journal Article, Review)
|
| Chemical References |
- Adjuvants, Immunologic
- Antigens, Bacterial
- Antitubercular Agents
- BCG Vaccine
- DNA, Bacterial
|
| Topics |
- Adjuvants, Immunologic
(therapeutic use)
- Antigens, Bacterial
(analysis)
- Antitubercular Agents
(therapeutic use)
- BCG Vaccine
(therapeutic use)
- Child
- DNA, Bacterial
(analysis)
- Diagnosis, Differential
- Humans
- Mycobacterium tuberculosis
(genetics, immunology, isolation & purification)
- Polymerase Chain Reaction
- Treatment Outcome
- Tuberculin Test
- Tuberculosis
(diagnosis, drug therapy, prevention & control)
|
